Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines

Research output: Contribution to journalLetterResearch

Standard

Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines. / Moghimi, Seyed Moien; Andersen, T. L.

In: Molecular Immunology, Vol. 46, 2009, p. 1571.

Research output: Contribution to journalLetterResearch

Harvard

Moghimi, SM & Andersen, TL 2009, 'Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines', Molecular Immunology, vol. 46, pp. 1571. https://doi.org/10.1016/j.molimm.2009.02.014

APA

Moghimi, S. M., & Andersen, T. L. (2009). Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines. Molecular Immunology, 46, 1571. https://doi.org/10.1016/j.molimm.2009.02.014

Vancouver

Moghimi SM, Andersen TL. Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines. Molecular Immunology. 2009;46:1571. https://doi.org/10.1016/j.molimm.2009.02.014

Author

Moghimi, Seyed Moien ; Andersen, T. L. / Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines. In: Molecular Immunology. 2009 ; Vol. 46. pp. 1571.

Bibtex

@article{d3f2d380753011de8bc9000ea68e967b,
title = "Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines",
abstract = "Udgivelsesdato: 2009",
keywords = "Former Faculty of Pharmaceutical Sciences",
author = "Moghimi, {Seyed Moien} and Andersen, {T. L.}",
year = "2009",
doi = "10.1016/j.molimm.2009.02.014",
language = "English",
volume = "46",
pages = "1571",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Pergamon Press",

}

RIS

TY - JOUR

T1 - Complement-mediated tumour growth: Implications for cancer nanotechnology and nanomedicines

AU - Moghimi, Seyed Moien

AU - Andersen, T. L.

PY - 2009

Y1 - 2009

N2 - Udgivelsesdato: 2009

AB - Udgivelsesdato: 2009

KW - Former Faculty of Pharmaceutical Sciences

U2 - 10.1016/j.molimm.2009.02.014

DO - 10.1016/j.molimm.2009.02.014

M3 - Letter

VL - 46

SP - 1571

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

ER -

ID: 13253531